Product Program year 2025 Source: CMS Open Payments

Atlas

Device Vascular/Oncology

PDI 00801741062780

Open in the dashboard

General payments

$3,224

128 payments

Research payments

$0

0 payments

Through program year 2025, $3,224 in general payments and $0 in research payments were reported against Atlas (Vascular/Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $1,183 40
2024 General $918 45
2023 General $1,123 43

Breakdown

Who paid General payments · program years 2023–2025
  1. Bard Peripheral Vascular, Inc. $2,400 99 payments
  2. Becton, Dickinson and Company $603 27 payments
  3. Davol Inc. $221 2 payments
Top recipients General payments · program year 2025
  1. Ramesh Gowda Interventional Cardiology · New York, NY $279 24% · 4 payments
  2. Eyad Ahmed Internal Medicine · Newark, NJ $110 9% · 1 payment
  3. Walter Sartor Surgery · Monroe, LA $53 4% · 1 payment
  4. William Liles Surgery · Monroe, LA $53 4% · 1 payment
  5. Michelle Shively Nurse Practitioner, Family · Mountain Home, TN $53 4% · 1 payment

The top 5 of 35 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $407 35% · 7 practitioners
  2. Vascular & Interventional Radiology Radiology $221 19% · 10 practitioners
  3. Internal Medicine $110 9% · 1 practitioner
  4. Surgery $106 9% · 2 practitioners
  5. Vascular Surgery Surgery $87 8% · 4 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $371 31% · 4 recipients
  2. Ohio $149 13% · 7 recipients
  3. Florida $142 12% · 8 recipients
  4. New Jersey $129 11% · 2 recipients
  5. Louisiana $106 9% · 2 recipients

The top 5 of 14 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

128 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record